Education
About Us
Working with TipRanks
Follow Us
GE Healthcare Technologies Inc (GEHC)
NASDAQ:GEHC
RESEARCH TOOLSreports
Earnings Data
Report Date
Jul 29, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.92Last Year’s EPS
1Same Quarter Last Year
Moderate Buy
Based on 14 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 30, 2025
|% Change Since: 2.61%
|Next Earnings Date:Jul 29, 2025
Earnings Call Sentiment|Neutral
GE Healthcare reported strong top-line growth and record orders, driven by robust demand in imaging and successful product launches. However, significant challenges remain due to tariff impacts on profit and cash flow, as well as market challenges in China.Company Guidance
During the GE HealthCare First Quarter 2025 Earnings Conference Call, the company provided updated guidance reflecting the impact of tariffs on their financial performance. The company reported an adjusted EPS impact of $0.85 due to tariffs for 2025, with a gross impact estimated at $1.75 per share before mitigation efforts. They have already managed to mitigate over 50% of the gross exposure, resulting in a net incremental impact of $0.80 per share, on top of the $0.05 impact included in February's guidance. GE HealthCare also forecasted full-year organic revenue growth between 2% and 3%, unchanged from prior estimates, and adjusted EBIT margin guidance was revised to a range of 14.2% to 14.4%, down from 16.7% to 16.8%. Additionally, the company anticipates delivering free cash flow of at least $1.2 billion for the full year, reduced from the previous expectation of $1.75 billion, primarily due to tariff-related costs.Record Double-Digit Orders Growth
GE Healthcare experienced record double-digit orders growth driven by strong U.S. market performance, particularly in imaging products for cardiology and oncology.
Strong Financial Performance
First quarter revenues were $4.8 billion with a 4% organic revenue growth. Adjusted EBIT margin increased by 30 basis points year-over-year, leading to a 12% year-over-year increase in adjusted EPS to $1.01.
Robust Demand in Imaging Segment
Imaging organic revenue grew by 5% year-over-year, and segment EBIT margin increased by 130 basis points due to productivity, volume, and price improvements.
Successful Product Launches
Launched Flyrcado, a new radiopharmaceutical product, and introduced Revolution Vibe, a dedicated cardiac CT system.
Significant Backlog Increase
Exited the quarter with a record backlog of $20.6 billion, an increase of $1.9 billion year-over-year.
---
GEHC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
GEHC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Apr 30, 2025 | $68.09 | $70.33 | +3.29% |
| Feb 13, 2025 | $85.86 | $93.43 | +8.82% |
| Oct 30, 2024 | $85.19 | $87.12 | +2.27% |
| Jul 31, 2024 | $82.54 | $84.52 | +2.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does GE Healthcare Technologies Inc (GEHC) report earnings?
GE Healthcare Technologies Inc (GEHC) is schdueled to report earning on Jul 29, 2025, TBA Not Confirmed.
What is GE Healthcare Technologies Inc (GEHC) earnings time?
GE Healthcare Technologies Inc (GEHC) earnings time is at Jul 29, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is GEHC EPS forecast?
GEHC EPS forecast for the fiscal quarter 2025 (Q2) is 0.92.
---